Black light does more than make posters glow. Cornell researchers have developed a chemical tool to control inflammation that is activated by ultraviolet (UV) light.
The method will allow scientists to study inflammation and the immune system, and may one day prove effective as a targeted therapy for inflammatory diseases, while minimizing side effects to healthy tissues.
The researchers, who reported their results in a study published in October in the journal Chemical Science, designed a small molecule that is capable of controlling an immune response when exposed to UV light radiation.
“Currently, there aren’t a lot of tools that are able to manipulate the immune system in a spatio-temporal fashion,” said Pamela Chang, assistant professor of microbiology and immunology, and the paper’s senior author. Bibudha Parasar, a graduate student in Chang’s lab, is the paper’s first author.
“We are pushing the forefront of developing new technologies to control inflammation and the immune system, with the ultimate goal of being able to study these biological pathways and perhaps develop therapies for inflammatory diseases,” Chang said.
Inflammation is caused by the immune system as one of the body’s responses to eliminate infectious pathogens and other foreign or dangerous agents. When inflammation becomes chronic, it can lead to a host of diseases, including asthma, multiple sclerosis, rheumatoid arthritis, colitis and Crohn’s disease.
The researchers created a chemical probe that inhibits a reaction mediated by enzymes called histone deacetylases (HDACs). These enzymes regulate genes that turn on when the immune system is challenged and promote inflammation. HDACs also have inhibitors that suppress this inflammatory response, and the probe specifically activates these inhibitors but only in the presence of UV light. This is especially useful since HDACs are ubiquitous and have other biological effects, and most drugs affect the entire system, leading to unintended consequences.
“If you turned off all the HDACs in the body, you would probably be hitting a lot of pathways that you didn’t want to turn off,” said Chang. “We can control when and where we turn off the HDACs using light. The idea is that you can actually target the tissue that has chronic inflammation and regulate it by selectively inhibiting HDACs in the tissue that’s affected.”
Photodynamic therapies are being developed and have existing infrastructure in the clinic for the potential use of the new tool to inhibit inflammation in patients with inflammatory diseases, Chang said.
Learn more: New tool uses UV light to control inflammation
Receive an email update when we add a new INFLAMMATION article.
The Latest on: Inflammation control
via Google News
The Latest on:Inflammation control
- Cycling hypoxia promotes a pro-inflammatory phenotype in macrophages via JNK/p65 signaling pathwayon January 22, 2020 at 2:19 pm
CyH amplified the pro-inflammatory phenotype of M1 macrophages evidenced by an increased pro-inflammatory ... A sample processed without reverse transcriptase enzyme was used as negative control for ...
- Thailand finds fourth China coronavirus infectionon January 22, 2020 at 1:19 pm
Thailand has quarantined a fourth patient with the new coronavirus including one Thai national, authorities said on Wednesday, days before the Lunar New Year holiday when thousands of Chinese tourists ...
- Hippocampal neural stem cells and microglia response to experimental inflammatory bowel disease (IBD)on January 22, 2020 at 7:52 am
resulting in compromised intestinal epithelial barrier and chronic mucosal inflammation. Patients with IBD present with increased incidence of psychiatric disorders and cognitive impairment.
- Pandemic Fears Grow as China Steps Up Efforts to Control New Flu-Like Coronaviruson January 22, 2020 at 5:38 am
President Donald Trump said the United States’ Centers for Disease Control and Prevention had a good containment plan ... “You have to rely on your immunity if you get an infection. It sounds very ...
- Global UV Infection Control Device Market Will Grow Over USD 5,500 Million by 2025on January 22, 2020 at 2:59 am
Zion Market Research added a new report “Global UV Infection Control Device Market Expected to Reach USD 5,500 Million by 2025" in its database, which provides an expert and in-depth analysis of key ...
- China at "crucial stage" to control novel coronavirus, experts sayon January 21, 2020 at 9:17 pm
Zeng Guang, chief epidemiologist of the Chinese Center for Disease Control and Prevention (China CDC), said no infections among children or students have been reported in Wuhan, and the infection ...
- Identifying Plants With Drones Could Be Key To Reducing A Parasitic Infectionon January 21, 2020 at 8:34 pm
Another option would be to physically remove the vegetation. Our team is testing the effectiveness of removing vegetation to reduce snail abundance and human infection burden. Ecology is the ...
- Gregg Jarrett: In Trump impeachment trial, Democrats continue inflammatory accusations with no basis in facton January 21, 2020 at 6:08 pm
House Intelligence Committee Chairman Adam Schiff of California, the leading House impeachment manager for Democrats, hurled the usual inflammatory accusations from his grab-bag of ... Senators may ...
- Association for Professionals in Infection Control and Epidemiology (APIC) Selects Sterifre Medical as a Strategic Partneron January 21, 2020 at 4:00 am
/PRNewswire/ -- Sterifre Medical, Inc., today announced that it is now an official Strategic Partner of the Association for Professionals in Infection ...
via Bing News